The North America Legal Marijuana Market size was valued at USD 15.9 billion in 2023 and is projected to reach USD 42.29 billion by 2032, exhibiting a CAGR of 15.0 % during the forecasts period. North America marijuana market also includes the growth, supply, and use and sale of marijuana for medical and recreational purposes due to emerging legislation. The medicinal cannabis is used in the treatment of chronic pain, anxiety, and other ailments; while the legalization of cannabis is enjoying increased acceptance for the use in recreational activities among adults. The market consists of varieties of products such as dried flower, oils, edibles and topicals. These trends are the further state-level legalization, the rising customers’ concern over quality and potency, and the improvement in the field of plant growing. The market is still relatively young, however the desire for this kind of energy storage continues to grow and with increased business interest will come increased legislative interest.

Introduction

New York, NY – January 22, 2025 – The Legal Marijuana Market size is expected to be worth around USD 86.3 Billion by 2033 from USD 19.4 Billion in 2023, growing at a CAGR of 16.1% during the forecast period from 2024 to 2033. In 2023, North America led the market, achieving over 75% share with a revenue of US$ 14.4 Billion.

The legal marijuana market is witnessing remarkable growth, driven by increasing legalization for medical and recreational use globally. As of 2023, over 50 countries have adopted legal frameworks to regulate cannabis, with prominent markets in North America, Europe, and emerging regions such as Asia-Pacific and Latin America. North America remains the largest market, with the United States leading due to widespread state-level legalization and Canada being the first G7 country to legalize cannabis nationwide.

Medical marijuana dominates the sector, fueled by growing recognition of its therapeutic benefits for conditions like chronic pain, epilepsy, and anxiety. Recreational use is also expanding rapidly, supported by shifting societal attitudes and government regulations. Innovations in product formats, including edibles, oils, and vapes, are attracting diverse consumer demographics. Additionally, significant investments in cannabis cultivation technologies and research are enhancing product quality and availability.

Despite regulatory complexities and stigma in certain regions, the global legal marijuana market is projected to grow exponentially. Industry experts anticipate a compound annual growth rate (CAGR) of over 20% from 2023 to 2030. This highlights the market's potential to generate substantial economic benefits, create jobs, and contribute to public health advancements through regulated cannabis use.

North America Legal Marijuana Market Outlook 2031

The North America legal marijuana market size was valued at USD 50.87 billion in 2022 and is anticipated to reach USD 184.63 billion by 2031 expand at a CAGR of 15.4% during the forecast period, 2023-2031. The growth of the market is attributed to the increasing adoption and acceptance towards legal marijuana in the treatment of various chronic diseases such as arthritis, Alzheimer’s and cancer along with neurological disorders including anxiety, epilepsy, and depression.



The legality of marijuana for recreational and medical purposes vary from country to country, be it in terms of distribution, cultivation & possession or on how each individual consumes it verses the medical conditions marijuana is supposed to use for.

The policies regarding the legality of cannabis are regulated and monitored by the three treaties of the United Nations, which are “the 1961 Single Convention on Narcotic Drugs”, “the 1971 Convention on Psychotropic Substances” and “the 1988 Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances”. As of now, marijuana is categorized as one variant of a Schedule I drug by the Single Convention Treaty.



This means that the participants are allowed to use under medical terms and prescriptions, however it is classified as an addictive drug along with a high risk of abuse. The usage of marijuana for leisure purposes is illegal in most of the countries in the globe. Nevertheless, many of these countries, including the North American countries, have adopted a decriminalization policy by making simple possession to a non-criminal offense, similar to traffic violations and parking tickets.



Medical marijuana are actually prescribed by physicians to patients from common diseases such as nausea and headaches to chemotherapy and other cancer diagnosis treatments. Marijuana does have short term side effects such as vomiting, dizziness, hallucinations and extreme tiredness. In the United States, as of 2020, 46% of their population currently live in the jurisdiction of the legalization of marijuana, be it recreational or medical.



The COVID-19 pandemic has hindered the growth of the North America legal marijuana market mainly because of the disruption caused in the marijuana supply chain management. The strict protocols enforced by the government authorities of various countries made distribution of cannabis more difficult than normal.



Social distancing and home lockdown meant that recreational activities took form in a digital aspect, meaning mariju

The North America Legal Marijuana report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

The North America Legal Cannabis Market size was valued at USD 18.3 billion in 2023 and is projected to reach USD 47.51 billion by 2032, exhibiting a CAGR of 14.6 % during the forecasts period. Legal cannabis market North America comprises the sale and governing of medical and recreational cannabis in North America. Medical marijuana is used as a pain reliever, an anxiety reliever, and for epilepsy treatment, while recreational use of marijuana is for fun. It is fueled by the improving legislation, changing attitude of people, and improvement in growing and supplying techniques. Some of the important trends are related to the intention towards cannabis-drinking products like edibles and beers, blockchain-automated systems for the interested supply chain, and massive investments for research and development of new medical applications and enhancements of the quality of the product.

The North America, Europe & Asia Pacific Legal Cannabis Market is estimated to be valued at USD 36.2 billion in 2025 and is projected to reach USD 345.7 billion by 2035, registering a compound annual growth rate (CAGR) of 25.3% over the forecast period.

This statistic shows the projected spending on legal cannabis in North America from 2017 to 2027. By 2027, spending on legal cannabis is expected to reach **** billion U.S. dollars in North America.

In North America Legal Cannabis Market is projected to grow from USD 17.8 billion in 2025 to USD 54.9 billion by 2031, at a CAGR of 20.7%

The North America legal cannabis market size was nearly USD 26.57 Billion in 2024. The industry is further expected to grow at a CAGR of 26.80% over the forecast period of 2025-2034 to attain USD 285.49 Billion by 2034.

The legal marijuana market is anticipated to experience significant growth over the forecast period, driven by the increasing legalization of cannabis for recreational and medicinal purposes, particularly in North America and Europe. The expansion of medical cannabis applications in treating various ailments, coupled with growing acceptance of cannabis as a therapeutic option, is fueling market growth. Additionally, advancements in cultivation techniques, such as indoor cultivation and genetic engineering, are leading to increased production efficiency and improved product quality, further boosting market demand. Market segmentation based on application (recreational and medical) and cultivation type (indoor, outdoor, and greenhouse) provides insights into specific growth dynamics. Key industry participants include Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., and MCig Inc., among others, who are actively involved in product development, strategic partnerships, and market expansion initiatives to gain a competitive edge. Regional analysis reveals substantial growth prospects in North America, particularly the United States and Canada, where regulatory frameworks are evolving favorably for the legal cannabis industry. Europe, with its growing medical cannabis market, also offers significant growth opportunities.

North America Legal Cannabis Market is expected to surpass the value of USD 112.0 Billion by 2035, expanding at a CAGR of 23.11% during the forecast period.

Snapshot img

Marijuana Market Size 2024-2028

The marijuana market size is forecast to increase by USD 87.8 billion at a CAGR of 32.14% between 2023 and 2028.

The market is experiencing significant growth due to the increasing legalization of cannabis for medical and recreational use in various regions. This trend is further fueled by the expansion of the e-commerce industry, enabling easier access to cannabis-infused edible products, CBD oil, and other cannabinoid-based offerings. However, the market also faces challenges such as the potential side effects associated with inappropriate use of medical marijuana and the need for effective pest control solutions to ensure product quality and safety. The cannabis industry is evolving rapidly, with a focus on innovation and compliance to meet the growing demand for CBD and other cannabinoid-based products.

What will be the Size of the Marijuana Market During the Forecast Period?

Request Free Sample

The market encompasses a diverse range of products derived from the Cannabis plant, including flowers, concentrates, edibles, topicals and tinctures. Two primary types of cannabis are commonly recognized: Cannabis sativa and Cannabis indica. THC (tetrahydrocannabinol) and CBD (cannabidiol) are the most prominent cannabinoids, with THC producing psychoactive effects and CBD offering therapeutic benefits. Medical cannabis and recreational cannabis are the two primary market segments. Medical cannabis is used to alleviate symptoms of various conditions, such as chemotherapy-induced nausea, while recreational cannabis is consumed for its psychoactive properties. CBD products, such as CBD gummies, have gained popularity due to their non-psychoactive nature and potential health benefits.
The market is continually evolving, with new products and innovations emerging regularly. Cannabinoids, including CBD (Epidiolex) and THC (Sativex, Marinol, Syndros, and others), are being developed and marketed as pharmaceuticals. The cannabis market is experiencing significant growth and is expected to continue expanding due to increasing legalization, consumer demand, and ongoing research and development.

How is this Marijuana Industry segmented and which is the largest segment?

The marijuana industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Medical marijuana
  Recreational marijuana


Type

  Oil and tinctures
  Flower


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  APAC



  South America



  Middle East and Africa

By Product Insights

The medical marijuana segment is estimated to witness significant growth during the forecast period. Medical marijuana is experiencing significant growth In the US market due to its potential therapeutic benefits for various health conditions. Chronic pain, including neuropathic and inflammatory pain, is one of the primary conditions treated with marijuana. The increasing prevalence of chronic pain among adults and the popularity of medical marijuana as a pain reliever are driving market expansion. Additionally, medical marijuana has shown promise in alleviating nausea caused by conditions such as Crohn's disease, acute gastritis, hypoglycemia, panic disorder, and arachnoiditis. Marijuana plants used for medicinal purposes include Cannabis indica, Cannabis sativa, and hybrids. The market for medical marijuana products, including flowers, concentrates, edibles, topicals, and tinctures, is expected to continue growing due to their potential therapeutic applications in treating conditions such as epilepsy, multiple sclerosis, anxiety, cancer, glaucoma, and insomnia.

Get a glance at the market report of share of various segments Request Free Sample

The Medical marijuana segment was valued at USD 9.19 billion in 2018 and showed a gradual increase during the forecast period. THC and CBD are the primary cannabinoids found in marijuana, with THC providing psychoactive effects and CBD offering therapeutic benefits without the high. Other cannabinoid-based products, such as Sativex, Marinol, Cesamet, and various cannabis-based products, are also gaining popularity for their medicinal applications. The legalization of marijuana for adult use in some states and continued clinical trials for various conditions are further fueling market growth.

Regional Analysis

North America is estimated to contribute 87% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, the legalization of marijuana for medical use is gaining momentum. In the US and Canada, marijuana is authorized for therapeutic ap

Legal Marijuana Market Outlook

According to our latest research, the global legal marijuana market size reached USD 39.5 billion in 2024, with a robust compound annual growth rate (CAGR) of 24.2% projected from 2025 to 2033. By 2033, the market is forecasted to attain a value of USD 277.6 billion, driven by the accelerating pace of legalization, expanding medical applications, and surging consumer acceptance worldwide. The legal marijuana market is experiencing exponential growth as governments relax regulations, allowing for increased investment, innovation, and accessibility across both medical and recreational uses.

One of the primary growth factors propelling the legal marijuana market is the rapidly evolving regulatory landscape. Countries such as Canada, the United States, Germany, and several Latin American nations have made significant strides in legalizing marijuana for both medicinal and recreational purposes. This shift is largely attributed to growing recognition of marijuanaÂ’s therapeutic benefits in treating chronic pain, neurological disorders, and mental health conditions. The destigmatization of cannabis, coupled with government-backed research and clinical trials, has led to a surge in product approvals and commercial launches, further expanding the marketÂ’s reach. Additionally, the increasing prevalence of chronic illnesses and the demand for alternative pain management solutions have significantly contributed to the adoption of legal marijuana, especially in regions with advanced healthcare infrastructure.

Another key driver is the innovation and diversification of marijuana-based products. Companies are investing heavily in research and development to create a wide variety of offerings, including edibles, concentrates, topicals, and beverages, catering to a broad spectrum of consumers. The rise of cannabidiol (CBD)-dominant and balanced THC & CBD products has attracted new demographics, including wellness-focused and elderly consumers seeking non-psychoactive solutions. This trend has also fostered the development of advanced cultivation technologies, precision dosing methods, and sustainable farming practices, enhancing product quality and consistency. The proliferation of online distribution channels and the emergence of branded dispensaries have further facilitated consumer access, convenience, and education, driving higher sales volumes and market penetration.

The legal marijuana market is also benefiting from significant capital inflows and strategic partnerships. Venture capitalists, institutional investors, and multinational corporations are increasingly recognizing the lucrative potential of the cannabis industry. This has resulted in a wave of mergers and acquisitions, cross-sector collaborations, and international expansions, strengthening supply chains and accelerating market growth. The integration of cannabis into mainstream wellness, pharmaceutical, and consumer goods sectors has opened new avenues for revenue generation and product innovation. Moreover, the development of standardized testing protocols and regulatory frameworks has enhanced consumer confidence, ensuring product safety and quality assurance.

The concept of Legal Cannabis is gaining traction globally, as more countries recognize the potential benefits of regulating cannabis use. Legal Cannabis refers to the controlled and regulated production, distribution, and consumption of cannabis products, ensuring safety and quality standards are met. This shift towards legalization is not only driven by the potential for economic growth but also by the demand for safe and reliable access to cannabis for both medical and recreational purposes. As governments implement regulatory frameworks, they are able to monitor and control the market, reducing the influence of illegal trade and ensuring consumer protection. This transition is also opening up new avenues for research and innovation, as companies explore the diverse applications of cannabis in health, wellness, and beyond.

From a regional perspective, North America continues to dominate the legal marijuana market, accounting for the largest share due to widespread legalization in the United States and Canada. Europe is emerging as a significant growth engine, driven by progressive policy changes in countri

The Medical Marijuana Market Report is Segmented by Formulation Type (Capsules, Oils, and More), Cannabinoid Composition (THC-Dominant, and More), Route of Administration (Oral, Inhalation, Sublingual, and More), Application (Chronic Pain, Arthritis, Migraine, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

The legal marijuana market is experiencing explosive growth, projected to reach $227.82 billion in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 26.2% from 2025 to 2033. This expansion is driven by several factors, including the increasing legalization of cannabis for both recreational and medical purposes across numerous jurisdictions globally. Consumer acceptance is rising steadily, fueled by growing awareness of cannabis' therapeutic benefits and a shift in social perceptions. Technological advancements in cultivation techniques, particularly indoor and greenhouse cultivation, are enhancing yields and product quality, further contributing to market growth. The diverse applications of cannabis, ranging from recreational use to pharmaceutical preparations, are creating numerous market opportunities. Leading companies such as Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., and MCig Inc. are actively shaping this dynamic landscape through innovation and strategic expansion. However, regulatory hurdles and varying legal frameworks across different regions continue to pose challenges to market penetration and standardization. Furthermore, concerns regarding potential public health impacts necessitate careful monitoring and responsible regulation to ensure sustainable market development. The substantial growth in the legal marijuana market is expected to continue through 2033, driven by further legalization efforts and increased consumer demand. Significant regional variations exist, with North America, particularly the United States and Canada, currently dominating the market. However, Europe and other regions are experiencing rapid growth as legalization gains momentum. The segmentation of the market by cultivation type (indoor, outdoor, greenhouse) and application (recreational, medical) highlights the diverse nature of the industry and its potential for future diversification. Future market expansion will likely depend on further regulatory reforms, advancements in cannabis-related research, and the development of innovative products tailored to meet diverse consumer preferences. The industry's trajectory points towards a mature market characterized by both significant economic value and a continuing evolution in cultivation practices and product offerings.

Legal Marijuana and Cannabis Market Outlook

The global market size for legal marijuana and cannabis was approximately USD 22.8 billion in 2023, with a projected growth to USD 97.35 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 17.2%. The primary growth factors fuelling this market include increasing legalization of cannabis for both medical and recreational use across various regions, growing acceptance of cannabis-derived products, and the expanding applications of cannabis in medical treatments and wellness products.

The continuous wave of legalization, particularly in North America and parts of Europe, has significantly bolstered the legal marijuana and cannabis market. Countries like Canada and several states within the U.S. have not only legalized medical marijuana but have also paved the way for recreational use, creating a broad and lucrative market. This legislative shift is encouraged by public demand and supported by the potential economic benefits, such as job creation and additional tax revenue, thereby fueling market growth.

Medical applications of cannabis are another significant driver of market expansion. The therapeutic benefits of cannabinoids, especially CBD (cannabidiol), have been recognized in treating a variety of conditions, including chronic pain, epilepsy, anxiety, and multiple sclerosis. Increasing research and clinical trials supporting the efficacy and safety of medical cannabis have led to growing acceptance among healthcare professionals and patients. This growing acknowledgment and the subsequent rise in prescriptions for medical marijuana are propelling the market forward.

Consumer attitudes towards cannabis are also evolving, resulting in increased market demand. A shift in perception towards viewing cannabis as a wellness product, similar to supplements and health-related products, is driving consumer interest. This shift is amplified by the proliferation of cannabis-infused products, such as edibles, topicals, and beverages, making cannabis consumption more accessible and socially acceptable. The diversification of product offerings is appealing to a broader consumer base, further contributing to market growth.

The debate over whether to legalize marijuana continues to be a significant topic in many regions, influencing both public policy and market dynamics. Advocates for legalization argue that it can lead to numerous benefits, including reducing the burden on the criminal justice system, creating economic opportunities, and providing a regulated framework for safer consumption. The potential tax revenue from legal marijuana sales is also a compelling argument for many governments, as it can be used to fund public services and infrastructure. Moreover, legalization can help in destigmatizing cannabis use, encouraging more research into its medical benefits, and ensuring that consumers have access to safe and quality products. As more regions consider the prospect of legalization, the market is poised to expand, offering new opportunities for businesses and consumers alike.

From a regional perspective, North America continues to dominate the legal marijuana and cannabis market, driven by the extensive legalization framework in the United States and Canada. Europe is also showing significant potential, with countries like Germany and the Netherlands leading in medical cannabis use. Meanwhile, the Asia Pacific region is gradually emerging, particularly as countries like Thailand and Australia relax their cannabis laws. These regional dynamics are critical in understanding the future trajectory of the global legal marijuana and cannabis market.

Product Type Analysis

The legal marijuana and cannabis market is segmented into various product types, including flower, concentrates, edibles, topicals, and others. The 'flower' segment remains one of the most popular and traditional forms of cannabis consumption, largely driven by the recreational market. Flower sales account for a significant portion of the market due to their ease of use and familiarity among consumers. The versatility of the flower, which can be smoked, vaped, or used in homemade edibles, maintains its strong market presence.

Concentrates, including oils, waxes, and shatters, represent a rapidly growing segment within the cannabis market. Concentrates are favored for their potency and the ability to offer higher doses of THC or CBD compared to traditional flower. The

According to Cognitive Market Research, the global Cannabis market size will be USD 58614.5 million in 2024. It will expand at the compound annual growth rate (CAGR) of 35.00% from the year 2024 to 2031.

North America held the primary market share for more than 40% of global revenue with a market size of USD 23445.80 million in 2024 and will rise at a compound annual growth rate (CAGR) of 33.2% from the year 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 17584.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 13481.34 million in 2024 and will rise at the compound annual growth rate (CAGR) of 37.0% from the year 2024 to 2031.
Latin America held a market share of more than 5% of global revenue with a market size of USD 2930.73 million in 2024 and will rise at the compound annual growth rate (CAGR) of 34.4% from the year 2024 to 2031.
Middle East and Africa held a market share of around 2% of global revenue and estimated at a market size of USD 1172.29 million in 2024 and will rise at the compound annual growth rate (CAGR) of 34.7% from the year 2024 to 2031.
The concentrates category is the fastest growing segment of the Cannabis industry

Market Dynamics of Cannabis Market

Key Drivers for Cannabis Market

Legalization and regulatory reforms are significantly driving the market

A primary driver of the cannabis market is the increasing wave of legalization and regulatory reforms across various regions. Governments and other organizational bodies are increasingly recognizing the medical and therapeutic benefits of cannabis, along with its potential to generate significant revenue, leading to progressively easing restrictions on cultivation, distribution and consumption.

Rising Demand for Medical Cannabis to Drive Market Growth

The increasing acceptance of cannabis for medical purposes is another major factor driving market growth. Scientific studies and clinical trials have highlighted the therapeutic benefits of cannabis compounds, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), in managing chronic pain, anxiety, epilepsy, and other conditions. This has led to growing prescriptions for cannabis-based medications in healthcare systems worldwide. The ageing global population and surging prevalence of chronic diseases have further spurred demand for medical cannabis as a natural and effective treatment option.

Restraint Factor for the Cannabis Market

Stringent Regulatory Frameworks and Legal Restrictions Will Limit Market Growth

The cannabis market faces significant restraints due to stringent regulatory frameworks and inconsistent legal statuses across different regions. While some countries and states have legalized medical or recreational cannabis, many others continue to impose strict prohibitions. Even in legalized areas, taxation policies, complex licensing requirements, and compliance costs pose challenges for market participants. These barriers limit market entry for smaller businesses and slow the expansion of cannabis-related products.

Trends in the Cannabis Market

The Expansion of Legalization Fuels Consumer and Investment Growth

The global cannabis market is undergoing significant changes due to the rising legalization of both medical and recreational cannabis in North America, Europe, and certain regions of Latin America. Nations like Canada, Germany, and various U.S. states are witnessing a surge in consumer demand, which is fostering the emergence of new startups, product innovation, and increased investment. This legal shift is also normalizing cannabis use and encouraging the growth of dispensaries, wellness products, and edibles.

The Growing Popularity of CBD-Infused Products in Health and Wellness

Cannabidiol (CBD), the non-psychoactive element of cannabis, is emerging as a significant player in the wellness, cosmetics, and functional food industries. Consumers are increasingly turning to CBD for its alleged health advantages, including stress relief, improved sleep, pain management, and anti-inflammatory effects. Consequently, a diverse array of CBD-infused products—spanning oils, gummies, skincare creams, and pet supplements—are entering the market.

Impact of Covid-19 on the Cannabis Market

The COVID-19 pandemic had a mixed impact on the cannabis market. On the po...

The global legal marijuana market is projected to reach a value of $73.6 billion by 2033, expanding at a CAGR of 16.5%. The market is witnessing significant growth due to the increasing acceptance of medical marijuana for treating various conditions, as well as the growing legalization of recreational marijuana in several countries. Additionally, the burgeoning demand for cannabis-based products such as edibles, topicals, and concentrates is expected to further fuel market growth. North America is the largest market for legal marijuana, accounting for over 70% of the global market share. The United States is the dominant market in the region, with California and Colorado being the key revenue-generating states. Europe is another major market for legal marijuana, with Germany and the United Kingdom leading the way. The Asia-Pacific region is expected to witness significant growth in the coming years, driven by the increasing legalization of medical marijuana in countries such as Thailand and Australia. Key companies operating in the market include Medicine Man, Canopy Growth, Aphria, Aurora Cannabis Inc., and mCig Inc. The global legal marijuana cannabis market is expected to grow at a significant CAGR of XX% over the forecast period, reaching a market value of USD XX billion by 2028. The legalization of medical and recreational marijuana in several countries, increasing awareness of its therapeutic benefits, and growing acceptance of cannabis products among consumers are driving the market growth.

Among cannabis companies that trade on major exchanges, Innovative Industrial and Green Thumb Industries, both U.S. companies, are the top two companies based on their market capitalization. As of the beginning of 2025, Innovative Industrial had a market capitalization of **** billion U.S. dollars. With the full name Innovative Industrial Properties Inc, the company is a real estate investment trust for the regulated cannabis industry. In contrast to that, most of the other companies in the ranking are involved in the development, production, and sales of cannabis products.The legal marijuana industry U.S. sales of legal cannabis have increased significantly in recent years. The increase in sales of legal cannabis can, among others, be attributed to the legalization of recreational cannabis in California (2018) and other U.S. states. Recreational marijuana Marijuana has many uses among consumers. A recent survey among U.S. residents indicated that among those that consume cannabis, the primary reason for consumption was relaxation, followed by stress relief. Marijuana can be consumed in various forms, including flower, edibles, concentrates and pills, to name a few. The most favored form of cannabis among U.S. consumers is flower. Despite its popularity, all forms of cannabis remain illegal under U.S. federal law. However, over time, the U.S. population has warmed up to the thought of legalizing marijuana. A survey conducted in October 2021 suggests that more than *** thirds of U.S. adults think that marijuana should be made legal.

Overview

New York, NY – April 25, 2025 The Global Legal Cannabis Market size is expected to be worth around USD 247.4 Billion by 2033 from USD 26.1 Billion in 2023, growing at a CAGR of 25.2% during the forecast period from 2024 to 2033.

The global legal cannabis market is projected to expand significantly, reaching USD 247.4 billion by 2033, up from USD 26.1 billion in 2023, growing at a CAGR of 25.2% during the forecast period (2024-2033). This growth is driven by increasing legalization of medical and recreational cannabis, rising consumer demand, and expanding research on cannabis-derived health benefits.

Medical cannabis is being widely adopted for its therapeutic properties, particularly in managing chronic pain, neurological disorders, and mental health conditions. Meanwhile, the recreational cannabis segment continues to grow as governments worldwide ease regulations and create structured legal frameworks.

North America currently dominates the market due to widespread legalization in the U.S. and Canada. However, Europe and Latin America are witnessing rapid growth as more countries move toward cannabis decriminalization. Additionally, advancements in CBD-based products, edibles, and cannabis-infused beverages are further driving market expansion.

Despite regulatory challenges and supply chain complexities, the legal cannabis industry presents immense opportunities for investment, innovation, and economic development. As legalization expands globally, companies are focusing on product diversification, partnerships, and sustainable cultivation practices to strengthen their market presence.